[33]BASEL MT, SHRESTHA TB, TROYER DL, et al. Protease-sensitive, polymercaged liposomes: a method for making highly targeted liposomes using triggered release. ACS Nano. 2011;5(3):2162-2175.

[34]王丁丁,孙中洋,南军,等.胞内酶敏感肿瘤靶向递药体系的合成及应用[J].西北药学杂志,2019,34(2):203-208.

[35]CALLMANN CE, BARBACK CV, THOMPSON MP, et al. Therapeutic Enzyme-Responsive Nanoparticles for Targeted Delivery and Accumulation in Tumors. Adv Mater. 2015;27(31):4611-4615.

[36]FENG Q, ZHANG Y, ZHANG W, et al. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography. Acta Biomater. 2016;38: 129-142.

[37]CABRAL H, MATSUMOTO Y, MIZUNO K, et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol. 2011;6(12):815-823.

[38]CHOI KY, SARAVANAKUMAR G, PARK JH, et al. Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer. Colloids Surf B Biointerfaces. 2012;99:82-94.

[39]HAN M, HUANG-FU MY, GUO WW, et al. MMP-2-Sensitive HA End-Conjugated Poly(amidoamine) Dendrimers via Click Reaction To Enhance Drug Penetration into Solid Tumor. ACS Appl Mater ;9(49):-.

[40]FERNANDES C, SUARES D, YERGERI MC. Tumor Microenvironment Targeted Nanotherapy. Front Pharmacol. 2018;9:1230.

[41]LI H, MITEVA M, KIRKBRIDE KC, et al. Dual MMP7-proximity-activated and folate receptor-targeted nanoparticles for siRNA 2015;16(1):192-201.

[42]GUO F, WU J, WU W, et al. PEGylated self-assembled enzyme-responsive nanoparticles for effective targeted therapy against lung tumors. J Nanobiotechnology. 2018;16(1):57.

[43]PENG ZH, KOPE?EK J. Enhancing Accumulation and Penetration of HPMA Copolymer-Doxorubicin Conjugates in 2D and 3D Prostate Cancer Cells via iRGD Conjugation with an MMP-2 Cleavable Spacer. J Am Chem Soc.2015;137(21):6726-6729.

[44]POPOVI? Z, LIU W, CHAUHAN VP, et al. A nanoparticle size series for in vivo fluorescence imaging. Angew Chem Int Ed Engl. 2010;49(46):8649-8652.

[45]ZHANG S, DENG G, LIU F, et al. Autocatalytic Delivery of Brain Tumortargeting, Size-shrinkable Nanoparticles for Treatment of Breast Cancer Brain Metastases. Adv Funct Mater. 2020;30(14):.

[46]SECRET E, KELLY SJ, CRANNELL KE, et al. Enzyme-responsive hydrogel microparticles for pulmonary drug delivery. ACS Appl Mater ;6(13):-.

[47]ZHANG X, WANG X, ZHONG W, et al. Matrix metalloproteinases-2/9-sensitive peptide-conjugated polymer micelles for site-specific release of drugs and enhancing tumor accumulation: preparation and in vitro and in vivo evaluation. Int J Nanomedicine. 2016;11:1643-1661.

[48]RUAN S, CAO X, CUN X, et al. Matrix metalloproteinase-sensitive sizeshrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release. Biomaterials. 2015;60:100-110.

[49]RUAN S, HU C, TANG X, et al. Increased Gold Nanoparticle Retention in Brain Tumors by in Situ Enzyme-Induced Aggregation. ACS ;10(11):-.

[50]PROETTO MT, CALLMANN CE, CLIFF J, et al. Tumor Retention of Enzyme-Responsive Pt(II) Drug-Loaded Nanoparticles Imaged by Nanoscale Secondary Ion Mass Spectrometry and Fluorescence Microscopy. ACS Cent Sci. 2018;4(11):1477-1484.

[51]LI J, XIAO S, XU Y, et al. Smart Asymmetric Vesicles with Triggered Availability of Inner Cell-Penetrating Shells for Specific Intracellular Drug Delivery. ACS Appl Mater Interfaces. 2017;9(21):-.

[52]RUAN S, QIN L, XIAO W, et al. Acid-Responsive Transferrin Dissociation and GLUT Mediated Exocytosis for Increased Blood-Brain Barrier Transcytosis and Programmed Glioma Targeting Delivery. Adv Funct Mater,2018;28(30):.

[53]ANSELMO AC, MITRAGOTRI S. Nanoparticles in the clinic. Bioeng Transl Med. 2016;1(1):10-29.

[54]CHATTERJEE N, BIVONA TG. Polytherapy and Targeted Cancer Drug Resistance. Trends Cancer. 2019;5(3):170-182.

文章来源：《肿瘤药学》 网址: http://www.zlyxzz.cn/qikandaodu/2021/0222/665.html